Chemotherapy before surgery for muscle invasive bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether giving chemotherapy before surgery helps people with muscle invasive bladder cancer live longer. It reviews the outcomes of patients who received this treatment to see if it improves survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18.
- You have been diagnosed with muscle invasive bladder cancer – cancer that has grown into the bladder muscle wall.
- You received chemotherapy with a platinum-based drug before surgery.
- Your cancer has not spread to other parts of the body.
- You did not have surgery as your first treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies giving cisplatin-based chemotherapy before surgery for certain newly diagnosed upper-urinary-tract urothelial cancers (kidney/ureter). It may help shrink the cancer and improve outcomes by treating microscopic disease earlier.
This trial tests a stronger chemotherapy regimen (gemcitabine and cisplatin) given before surgery to remove the bladder. The goal is to shrink the cancer and improve the chances of successful surgery.
This trial tests giving chemotherapy before surgery to remove the bladder, to see if it can improve outcomes for patients with muscle-invasive bladder cancer. The treatment is personalized based on a lab test of your tumor cells, which may help make the therapy more effective.
This study looks at how well MRI scans can detect bladder cancer after chemotherapy, before surgery to remove the bladder. It may help doctors know if the chemo is working.
This trial compares three standard treatments for muscle-invasive bladder cancer: bladder removal surgery, radiation combined with chemotherapy, or both. It aims to find which approach works best while preserving quality of life.
This trial studies how well certain markers in bladder cancer tissue can predict which patients will respond to chemotherapy given before surgery. This may help doctors choose the best treatment for each patient in the future.
Hear when a new Bladder Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.